Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)

NCT00388193 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00388193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00388193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)
Lead sponsor
PETHEMA Foundation
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
December 31, 2013
Enrollment
20 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, burkitt's lymphoma